Tissue 65Zinc translocation in a rat model of chronic aldosteronism

Journal of Cardiovascular Pharmacology

Volumn 51, Issue 4, 2008, Pages 359-364

  Selektor, Yelena ^a   Parker, Robert B ^b   Sun, Yao ^a   Zhao, Wenyuan ^a   Bhattacharya, Syamal K ^a   Weber, Karl T ^a,b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Aldosteronism; Injured tissue; Zinc radioactivity

Indexed keywords

METALLOTHIONEIN; SODIUM CHLORIDE; ZINC 65;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BONE TISSUE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG UPTAKE; GENDER; HEART; HEART INJURY; HOMEOSTASIS; HYPERALDOSTERONISM; KIDNEY INJURY; KIDNEY PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RAT; SKELETAL MUSCLE; SPLEEN; TISSUE DISTRIBUTION; UPREGULATION; VASCULAR DISEASE;

ANIMALS; BONE RESORPTION; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FECES; HYPERALDOSTERONISM; KIDNEY; LIVER; MALE; METALLOTHIONEIN; MUSCLE, SKELETAL; NEPHRECTOMY; ORGAN SPECIFICITY; RATS; RATS, SPRAGUE-DAWLEY; ZINC; ZINC RADIOISOTOPES;

EID: 42449090342     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e318165b96e     Document Type: Article

References (46)

1. Hambidge M. Human zinc deficiency. J Nutr. 2000;130(Suppl 5S):1344S-1349S.
2. Sun Y, Cleutjens JPM, Diaz-Arias AA, et al. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res. 1994;28:1423-1432.
3. Cleutjens JPM, Kandala JC, Guarda E, et al. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol. 1995;27:1281-1292.
4. Agay D, Anderson RA, Sandre C, et al. Alterations of antioxidant trace elements (Zn, Se, Cu) and related metallo-enzymes in plasma and tissues following burn injury in rats. Burns. 2005;31:366-371.
5. Voruganti VS, Klein GL, Lu HX, et al. Impaired zinc and copper status in children with burn injuries: need to reassess nutritional requirements. Burns. 2005;31:711-716.
6. Tan IK, Chua KS, Toh AK. Serum magnesium, copper, and zinc concentrations in acute myocardial infarction. J Clin Lab Anal. 1992;6:324-328.
7. Arnaud J, Faure H, Bourlard P, et al. Longitudinal changes in serum zinc concentration and distribution after acute myocardial infarction. Clin Chim Acta. 1994;230:147-156.
8. Lekakis J, Kalofoutis A. Zinc concentrations in serum as related to myocardial infarction. Clin Chem. 1980;26:1660-1661.
9. Altekin E, Coker C, Sisman AR, et al. The relationship between trace elements and cardiac markers in acute coronary syndromes. J Trace Elem Med Biol. 2005;18:235-242.
10. Sahin E, Gümüşlü S. Stress-dependent induction of protein oxidation, lipid peroxidation and anti-oxidants in peripheral tissues of rats: comparison of three stress models (immobilization, cold and immobilization-cold). Clin Exp Pharmacol Physiol. 2007;34:425-431.
11. Cousins RJ, Dunn MA, Leinart AS, et al. Coordinate regulation of zinc metabolism and metallothionein gene expression in rats. Am J Physiol. 1986;251:E688-E694.
12. Dunn MA, Cousins RJ. Kinetics of zinc metabolism in the rat: effect of dibutyryl cAMP. Am J Physiol. 1989;256:E420-E430.
13. Koyanagi A, Kuffo D, Gresely L, et al. Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis. Ann Trop Med Parasitol. 2004;98:391-399.
14. Mayland C, Allen KR, Degg TJ, et al. Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response. Ann Clin Biochem. 2004;41:138-141.
15. Windram JD, Loh PH, Rigby AS, et al. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J. 2007;153:1048-1055.
16. Arroyo M, LaGuardia SP, Bhattacharya SK, et al. Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res. 2006;148:301-308.
17. Zozaya JL. Nutritional factors in high blood pressure. J Hum Hypertens. 2000;14(Suppl 1):S100-S104.
18. Pironi L, Miglioli M, Ruggeri E, et al. Nutritional status of patients undergoing ileal pouch-anal anastomosis. Clin Nutr. 1991;10:292-297.
19. Thomas M, Vidal A, Bhattacharya SK, et al. Zinc dyshomeostasis in rats with aldosteronism. Response to spironolactone. Am J Physiol Heart Circ Physiol. 2007;293:H2361-H2366.
20. Sun Y, Zhang J, Lu L, et al. Aldosterone-induced inflammation in the rat heart. Role of oxidative stress. Am J Pathol. 2002;161:1773-1781.
21. Sun Y, Zhang J, Zhang JQ, et al. Local angiotensin II and transforming growth factor-β1 in renalfibrosis of rats. Hypertension. 2000;35:1078-1084.
22. Moser-Veillon PB. Zinc needs and homeostasis during lactation. Analyst. 1995;120:895-897.
23. Gerling IC, Sun Y, Ahokas RA, et al. Aldosteronism: an immunostimulatory state precedes the proinflammatory/fibrogenic cardiac phenotype. Am J Physiol Heart Circ Physiol. 2003;285:H813-H821.
24. Chhokar VS, Sun Y, Bhattacharya SK, et al. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation. 2005;111:871-878.
25. 2 in peripheral blood mononuclear cells. Circulation. 2005;111:51-57.
26. Ahokas RA, Warrington KJ, Gerling IC, et al. Aldosteronism and peripheral blood mononuclear cell activation. A neuroendocrine-immune interface. Circ Res. 2003;93:e124-e135.
27. Chhokar VS, Sun Y, Bhattacharya SK, et al. Loss of bone minerals and strength in rats with aldosteronism. Am J Physiol Heart Circ Physiol. 2004;287:H2023-H2026.
28. Vidal A, Sun Y, Bhattacharya SK, et al. The calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol. 2006;290:H286-H294.
29. Mager H, Göller G. Resampling methods in sparse sampling situations in preclinical pharmacokinetic studies. J Pharm Sci. 1998;87:372-378.
30. Lansdown AB, Sampson B, Rowe A. Sequential changes in trace metal, metallothionein and calmodulin concentrations in healing skin wounds. J Anat. 1999;195(Pt 3):375-386.
31. Iwata M, Takebayashi T, Ohta H, et al. Zinc accumulation and metallothionein gene expression in the proliferating epidermis during wound healing in mouse skin. Histochem Cell Biol. 1999;112:283-290.
32. Mervaala EM, Müller DN, Park JK, et al. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension. Hypertension. 1999;33(1 Pt 2):389-395.
33. Muller DN, Dechend R, Mervaala EM, et al. NF-κB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension. 2000;35(1 Pt 2):193-201.
34. Yarom R, Wisenberg E, Peters PD, et al. Zinc distribution in injured myocardium. EMMA-4 examinations of dogs' hearts after coronary ligation. Virchows Arch B Cell Pathol. 1977;23:65-77.
35. Scibior A, Zaporowska H. Effects of vanadium(V) and/or chromium(III) on L-ascorbic acid and glutathione as well as iron, zinc, and copper levels in rat liver and kidney. J Toxicol Environ Health A. 2007;70:696-704.
36. Song Y, Wang J, Li Y, et al. Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury. Am J Pathol. 2005;167:17-26.
37. Karagulova G, Yue Y, Moreyra A, et al. Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther. 2007;321:517-525.
38. Andrews GK. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol. 2000;59:95-104.
39. Sato S, Shimizu M, Hosokawa T, et al. Distribution of zinc-binding metallothionein in cirrhotic liver of rats administered zinc. Pharmacol Toxicol. 2000;87:292-296.
40. Wang ZH, Iguchi H, Ohshio G, et al. Increased pancreatic metallothionein and glutathione levels: protecting against cerulein- and taurocholate-induced acute pancreatitis in rats. Pancreas. 1996;13:173-183.
41. Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract. 2006;21:438-449.
42. Singal PK, Kapur N, Dhillon KS, et al. Role of free radicals in catecholamine-induced cardiomyopathy. Can J Physiol Pharmacol. 1982;60:1390-1397.
43. Wang J, Song Y, Elsherif L, et al. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation. 2006;113:544-554.
44. Cho K, Adamson L, Jeong J, et al. Alterations in the levels of metallothionein and metals in the liver, and unique serum liver enzyme response in metallothionein knock-out mice after burn injury. Pathobiology. 2004;71:223-230.
45. van Rij AM, Hall MT, Bray JT, et al. Zinc as an integral component of the metabolic response to trauma. Surg Gynecol Obstet. 1981;153:677-682.
46. Uchiyama S, Yamaguchi M. Alteration in serum and bone component findings induced in streptozotocin-diabetic rats is restored by zinc acexamate. Int J Mol Med. 2003;12:949-954.